Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes.
Literal federal measure citations: H.R. 1
Source-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- THE NICKLES GROUP, LLC
- Client
- AMGEN
- Filing UUID
- 181b4a7f-c15f-4325-8595-57a04c2774d1
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Monitored implementation of P.L. 117-169, the Inflation Reduction Act as it relates to drug pricing. Issues related to biosimilars. Monitored issues related to cardiovascular health. Issues related to pharmacy benefit management. Monitored issues related to dialysis services. H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to pharmacy benefit management and drug pricing policies. Issues related to the Most Favored Nation drug pricing.
Literal federal measure citations: H.R. 1
Issues related to pharmacy benefit management. Issues related to cardiovascular care. Issues related to drug pricing.
Monitored issues related to intellectual property.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.